RSK activation is controlled by canonical Ras/mitogen-activated protein kinase (MAPK) pathway therefore, we questioned whether ERK mediated RSK phosphorylation in WA-treated HCC cells. The gene discussed is WNK2; the disease is hepatocellular carcinoma.